| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/17/2011 | CN102151336A Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 08/17/2011 | CN102151335A Regulation of metabolism by protein lysine acetylation modification |
| 08/17/2011 | CN102151334A Antibody against a tumor-specific antigen as target |
| 08/17/2011 | CN102151329A Antitumor composition and preparation method thereof |
| 08/17/2011 | CN102151325A Traditional Chinese medicine for treating breast diseases |
| 08/17/2011 | CN102151323A Drug prescription for treating cancer |
| 08/17/2011 | CN102151297A Compound ganoderma lucidum spore soft capsule and preparation method thereof |
| 08/17/2011 | CN102151294A Heat-nourishing sedum kamtschaticum and cordyceps militaris wine |
| 08/17/2011 | CN102151293A Preparation method of plant extractive and use |
| 08/17/2011 | CN102151291A Use of antrodia camphorata for treating diseases |
| 08/17/2011 | CN102151282A Application of iridoid glycoside and derivatives thereof as plasmin inhibitor and medicine composites of plasmin inhibitor |
| 08/17/2011 | CN102151279A Application of feather cockscomb saponins compound in antitumor or anti-inflammatory medicines |
| 08/17/2011 | CN102151277A Application of fulvestrant in preparing antimicrotubular chemotherapeutic drug resistance reversal agent |
| 08/17/2011 | CN102151276A Pancreatic cancer resistance effect and pharmaceutical preparation of crataegolic acid |
| 08/17/2011 | CN102151275A Pancreatic cancer-resisting effect of oleanolic acid and pharmaceutical preparation of oleanolic acid |
| 08/17/2011 | CN102151272A Polo like kinase1 (PLK1) inhibitor and use thereof |
| 08/17/2011 | CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 08/17/2011 | CN102151260A Andrographolide and berberine combination and application thereof |
| 08/17/2011 | CN102151257A Busulfan injection and preparation method thereof |
| 08/17/2011 | CN102151249A Medical composition of vinflunine |
| 08/17/2011 | CN102151248A 9-nitrocamptothecin freeze-dried powder injection and preparation method thereof |
| 08/17/2011 | CN102151243A Paclitaxel injection and preparation method thereof |
| 08/17/2011 | CN102150820A Method for preparing capsorubin and lycopene soft capsules |
| 08/17/2011 | CN101824096B Preparation method of vine of multiflower knotweed polysaccharide |
| 08/17/2011 | CN101810651B Preparation method of kiwifruit frozen and dried fruit vegetable product with function of tumor inhibition |
| 08/17/2011 | CN101775401B Rana chensinensis functional gene Rd-RNase3 sequence, construction method and amino acid sequence and application thereof |
| 08/17/2011 | CN101744874B Compound bee emulsion for resisting tumor and preparation method thereof |
| 08/17/2011 | CN101744847B Agaricus compound polysaccharide capsule preparation method |
| 08/17/2011 | CN101643471B C3/C3 fluoroquinolone dimmer derivative using oxadiazole as connection chain as well as preparation method and application thereof |
| 08/17/2011 | CN101632812B Traditional Chinese medicine oral liquid and preparation method thereof |
| 08/17/2011 | CN101612234B Traditional Chinese medicine processing method |
| 08/17/2011 | CN101597288B 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof |
| 08/17/2011 | CN101591321B Method for preparing 5,6,7,4'-tetrahydroxyflavone |
| 08/17/2011 | CN101570530B Method for preparing flavonoid dimeric compound as well as medium and preparation method thereof |
| 08/17/2011 | CN101538572B Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof |
| 08/17/2011 | CN101537144B Chinese material medical preparation for treating esophagus cancer and gastric cancer of digestive system |
| 08/17/2011 | CN101531630B Asymmetric chiral double-Schiff base simple synthesizing method |
| 08/17/2011 | CN101503407B Imidazopyridine compound |
| 08/17/2011 | CN101502506B Medical use of 3-(3,4-dihydroxyphenyl)-acrylic acid 2-(3,4-dihydroxyphenyl)-ethyl ester |
| 08/17/2011 | CN101492475B Tetraphenyl stibium dicarboxylic acid complex, preparation and uses thereof |
| 08/17/2011 | CN101475996B Novel use of alpha-fetoprotein and encoding gene thereof |
| 08/17/2011 | CN101463062B Compound separated from Gynostemma pentaphylla total saponin acid hydrolysis products |
| 08/17/2011 | CN101455736B Use of wild jujube seeds extract |
| 08/17/2011 | CN101439189B Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 08/17/2011 | CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 08/17/2011 | CN101323629B 4-{6-[5-(2-chlorinde-6- methylaniline formyl)-thiazole-2-amido]-2-methyl pyrimidine-4}-piperazine-1- diethyl methylphosphate |
| 08/17/2011 | CN101307052B Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof |
| 08/17/2011 | CN101302249B Self-assembly short peptide and use thereof in antineoplastic medicine preparation |
| 08/17/2011 | CN101279901B Honokiol series derivates, preparation and use thereof |
| 08/17/2011 | CN101163710B Phosphine transition metal complex, process for producing the same and anticancer drug containing the same |
| 08/17/2011 | CN101002772B Nanometer particle targeted preparation of hydroxycamptothecine, and its preparing method |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2011 | US7998966 Axl kinase inhibitors |
| 08/16/2011 | US7998947 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998934 PAI-2 conjugates for the treatment and imaging of cancer |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | CA2629777C Spirocyclic compounds as hdac inhibitors |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2499593C Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 08/16/2011 | CA2472880C Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 08/16/2011 | CA2467773C Acyloxymethyl esters of c4-16 n-alkane-dicarboxylic acids for the treatment of acne and other related skin disorders |
| 08/16/2011 | CA2464770C Compound |
| 08/16/2011 | CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
| 08/16/2011 | CA2450660C Lactone formulations and method of use |
| 08/16/2011 | CA2401624C Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/16/2011 | CA2397590C Antisense inhibition of ptp1b expression |
| 08/16/2011 | CA2389979C Methods of inhibiting metastasis |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2376164C Intermolecularly associating compounds, and aggregates comprising them |
| 08/16/2011 | CA2369270C Camptothecin analogs and methods of preparation thereof |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/16/2011 | CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097594A2 Therapeutic methods and compositions involving allosteric kinase inhibition |
| 08/11/2011 | WO2011097581A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
| 08/11/2011 | WO2011097573A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells |
| 08/11/2011 | WO2011097526A1 Compounds and compositions as protein kinase inhibitors |
| 08/11/2011 | WO2011097522A2 Combination methods for treatment of disease |
| 08/11/2011 | WO2011097500A2 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 08/11/2011 | WO2011097384A2 Tumor targeted delivery of immunomodulators by nanoplymers |
| 08/11/2011 | WO2011097381A2 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof |
| 08/11/2011 | WO2011097331A1 Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f] [1,2,4] triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide |
| 08/11/2011 | WO2011097317A1 Use of n1,n4-bis[3-(ethylamino)propyl]-2-butene-1,4-diamine compounds in combination with epigenetic-acting pharmaceuticals for enhanced cancer therapy |
| 08/11/2011 | WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| 08/11/2011 | WO2011096756A2 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
| 08/11/2011 | WO2011096676A2 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors |
| 08/11/2011 | WO2011096536A1 Novel synthetic glycolipid and use thereof |
| 08/11/2011 | WO2011096535A1 Pharmaceutical agent for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096534A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096533A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096528A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096519A1 Medicinal composition for treating and/or preventing cancer |
| 08/11/2011 | WO2011096517A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096504A1 Method for producing nk cell enhancement-type blood product |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096438A1 Method and pharmaceutical composition for treatment of intestinal disease |